Αποτελέσματα Αναζήτησης
21 Απρ 2024 · Learn about the factors that affect life expectancy for people with ALS, a neurodegenerative condition that causes muscle weakness and paralysis. Find out about the medications and interventions that may slow the progression and improve quality of life.
The median survival time from onset to death ranges from 20 to 48 months, but 10–20% of ALS patients have a survival longer than 10 years. Older age and bulbar onset are consistently reported to have a worse outcome. There are conflicting data on gender, diagnostic delay and El Escorial criteria.
Survival from diagnosis varies considerably. Several prognostic factors are known, including site of onset (bulbar or limb), age at symptom onset, delay from onset to diagnosis and the use of riluzole and non-invasive ventilation (NIV).
Death from ALS generally occurs within two to four years from diagnosis from respiratory failure, although more slowly progressive forms of the illness occur in a small proportion of patients.
4 Ιαν 2021 · Amyotrophic lateral sclerosis (ALS) develops into a life-threatening condition 2 to 4 years after the onset of symptoms. Although many people with the disease decide in favour of life-sustaining measures, thoughts about hastening death are not uncommon.
10 Απρ 2024 · The most common cause of death for people with ALS is breathing failure. Half of people with ALS die within 14 to 18 months of diagnosis. However, some people with ALS live 10 years or longer.
8 Δεκ 2023 · The two systems include gradually worsening progression, acknowledging that some aspects of ALS might occur in varied sequences. Each contains progressive stages that end in stage 5 (death). Even with treatment, ALS stages progress in severity and do not improve.
